MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids in diagnosing Developmental and Epileptic Encephalopathy 12, revealing WWOX gene mutations for personalized treatment strategies.
Explore genetic testing for DEE7, focusing on early diagnosis, personalized treatments, and family planning. Gain insights into challenges and solutions for effective management.
Unlock the key to diagnosing Dilated Cardiomyopathy 1HH with genetic testing. Early detection, personalized treatment, and informed family planning await.
Genetic testing reveals key insights into Dilated Cardiomyopathy 1U, offering early detection, personalized treatment, and family risk assessment strategies.
Unravel Dilated Cardiomyopathy 1V's genetic roots. Explore how early detection and personalized care through genetic testing can transform heart disease management.
Genetic testing unveils the link between early repolarization and ventricular fibrillation, aiding in risk stratification and personalized cardiac care strategies.
Uncover FAME3's genetic complexity, accurate diagnosis, and personalized treatments through genetic testing, aiding in management and informed family planning.
Genetic testing is key in diagnosing Episodic Ataxia Type 5. Explore its role in early detection, personalized treatment, and advancing medical research.